Recent advances in the treatment of non-small cell lung cancer with MET inhibitors

Recent advances in the treatment of non-small cell lung cancer with MET inhibitors

Recently, research into the oncogenic driver genes associated with non-small cell lung cancer (NSCLC) has advanced significantly, leading to the development and clinical application of an increasing number of approved therapeutic agents. Among these, small molecule inhibitors that target mesenchymal...

Full description

Saved in:
Bibliographic Details
Main Authors: Dongna Zhang, Wenying Zhang, He Liu, Pan Liu, Chunxin Li, Yangyang Liu, Jicheng Han, Guangze Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Chemistry
Subjects:
NSCLC
MET inhibitors
drug discovery
structure-activity relationships
targeted therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2024.1501844/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fchem.2024.1501844/full

Similar Items